Companies / Slovenia
Krka Maintains Positive Outlook
February 2007 | Company Finance AlertOn the back of impressive 2006 financial results, Slovenian drugmaker Krka is looking to further penetrate emerging markets, continue to upscale its R&D capabilities, get more products approved and invest in infrastructure to ensure future growth.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
